Cargando…

The Impact of COVID-19 on Brain Stimulation Therapy

Among the far-reaching effects of the COVID-19 pandemic has been restricted access to safe and effective forms of psychiatric treatment. Focusing on electroconvulsive therapy and transcranial magnetic stimulation, we review the pandemic's impact on brain stimulation therapy by asking 3 fundamen...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffey, Michael Justin, Kerns, Suzanne, Sanghani, Sohag, Wachtel, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801771/
https://www.ncbi.nlm.nih.gov/pubmed/35219433
http://dx.doi.org/10.1016/j.psc.2021.11.008
_version_ 1784642536526053376
author Coffey, Michael Justin
Kerns, Suzanne
Sanghani, Sohag
Wachtel, Lee
author_facet Coffey, Michael Justin
Kerns, Suzanne
Sanghani, Sohag
Wachtel, Lee
author_sort Coffey, Michael Justin
collection PubMed
description Among the far-reaching effects of the COVID-19 pandemic has been restricted access to safe and effective forms of psychiatric treatment. Focusing on electroconvulsive therapy and transcranial magnetic stimulation, we review the pandemic's impact on brain stimulation therapy by asking 3 fundamental questions—Where have we been? How are we doing? And where are we going?
format Online
Article
Text
id pubmed-8801771
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88017712022-01-31 The Impact of COVID-19 on Brain Stimulation Therapy Coffey, Michael Justin Kerns, Suzanne Sanghani, Sohag Wachtel, Lee Psychiatr Clin North Am Article Among the far-reaching effects of the COVID-19 pandemic has been restricted access to safe and effective forms of psychiatric treatment. Focusing on electroconvulsive therapy and transcranial magnetic stimulation, we review the pandemic's impact on brain stimulation therapy by asking 3 fundamental questions—Where have we been? How are we doing? And where are we going? Elsevier Inc. 2022-03 2021-11-16 /pmc/articles/PMC8801771/ /pubmed/35219433 http://dx.doi.org/10.1016/j.psc.2021.11.008 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Coffey, Michael Justin
Kerns, Suzanne
Sanghani, Sohag
Wachtel, Lee
The Impact of COVID-19 on Brain Stimulation Therapy
title The Impact of COVID-19 on Brain Stimulation Therapy
title_full The Impact of COVID-19 on Brain Stimulation Therapy
title_fullStr The Impact of COVID-19 on Brain Stimulation Therapy
title_full_unstemmed The Impact of COVID-19 on Brain Stimulation Therapy
title_short The Impact of COVID-19 on Brain Stimulation Therapy
title_sort impact of covid-19 on brain stimulation therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801771/
https://www.ncbi.nlm.nih.gov/pubmed/35219433
http://dx.doi.org/10.1016/j.psc.2021.11.008
work_keys_str_mv AT coffeymichaeljustin theimpactofcovid19onbrainstimulationtherapy
AT kernssuzanne theimpactofcovid19onbrainstimulationtherapy
AT sanghanisohag theimpactofcovid19onbrainstimulationtherapy
AT wachtellee theimpactofcovid19onbrainstimulationtherapy
AT coffeymichaeljustin impactofcovid19onbrainstimulationtherapy
AT kernssuzanne impactofcovid19onbrainstimulationtherapy
AT sanghanisohag impactofcovid19onbrainstimulationtherapy
AT wachtellee impactofcovid19onbrainstimulationtherapy